Cargando…
Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731100/ https://www.ncbi.nlm.nih.gov/pubmed/31523396 http://dx.doi.org/10.18632/oncotarget.27175 |
_version_ | 1783449632099008512 |
---|---|
author | Nguyen, Tri Parker, Rebecca Hawkins, Elisa Holkova, Beata Yazbeck, Victor Kolluri, Akhil Kmieciak, Maciej Rahmani, Mohamed Grant, Steven |
author_facet | Nguyen, Tri Parker, Rebecca Hawkins, Elisa Holkova, Beata Yazbeck, Victor Kolluri, Akhil Kmieciak, Maciej Rahmani, Mohamed Grant, Steven |
author_sort | Nguyen, Tri |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6731100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-67311002019-09-13 Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms Nguyen, Tri Parker, Rebecca Hawkins, Elisa Holkova, Beata Yazbeck, Victor Kolluri, Akhil Kmieciak, Maciej Rahmani, Mohamed Grant, Steven Oncotarget Correction Impact Journals LLC 2019-09-03 /pmc/articles/PMC6731100/ /pubmed/31523396 http://dx.doi.org/10.18632/oncotarget.27175 Text en Copyright: © 2019 Nguyen et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Nguyen, Tri Parker, Rebecca Hawkins, Elisa Holkova, Beata Yazbeck, Victor Kolluri, Akhil Kmieciak, Maciej Rahmani, Mohamed Grant, Steven Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms |
title | Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms |
title_full | Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms |
title_fullStr | Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms |
title_full_unstemmed | Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms |
title_short | Correction: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms |
title_sort | correction: synergistic interactions between plk1 and hdac inhibitors in non-hodgkin’s lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731100/ https://www.ncbi.nlm.nih.gov/pubmed/31523396 http://dx.doi.org/10.18632/oncotarget.27175 |
work_keys_str_mv | AT nguyentri correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms AT parkerrebecca correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms AT hawkinselisa correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms AT holkovabeata correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms AT yazbeckvictor correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms AT kolluriakhil correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms AT kmieciakmaciej correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms AT rahmanimohamed correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms AT grantsteven correctionsynergisticinteractionsbetweenplk1andhdacinhibitorsinnonhodgkinslymphomacellsoccurinvitroandinvivoandproceedthroughmultiplemechanisms |